They should be more informed. The study also examined whether oral hormone replacement therapy had any effect on the development of cervical cellular abnormalities. Researchers found hormone replacement therapy did not significantly affect the incidence of abnormalities over the two-year period. This means a woman who has a long history of normal Pap smears and who is over 50 years old has a very low risk of developing new cervical disease. We should be focusing more of our efforts on screening unscreened and poorly-screened women.
Smoking is another risk factor for cervical cancer.
This article was prepared by Women's Health Weekly editors from staff and other reports. This information is provided for educational purposes only. Please read the disclaimer .